Injectable magnesium oxychloride cement foam (mocf)-derived scaffold for treating osteoporotic bone defects
US-2024108785-A1 · Apr 4, 2024 · US
US9226993B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9226993-B2 |
| Application number | US-21671808-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2008 |
| Priority date | Jul 10, 2008 |
| Publication date | Jan 5, 2016 |
| Grant date | Jan 5, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to methods for preparing porous natural or synthetic material scaffolds with keratin for improving cell affinity.
Opening claim text (preview).
The invention claimed is: 1. A method for combining a cell adhesion-enhancing keratin with a biomaterial scaffold, comprising the steps of: (a) mixing keratin with a biomaterial to form a keratin-biomaterial solution; (b) mixing porogen with said keratin-biomaterial solution to form a body; (c) drying said body; and (d) dissolving and leaching out the porogen from said body. 2. The method of claim 1 , wherein said method is a continuous process. 3. The method of claim 1 , wherein said method is a batch process. 4. The method of claim 1 , wherein said keratin includes a liquid. 5. The method of claim 4 , wherein said keratin is at least one of a solution, a suspension, a slurry, flowable powder, flowable fiber, flowable paste, and mixtures thereof. 6. The method of claim 1 , wherein said porogen is selected from the group consisting of sodium chloride, sodium sulfate, potassium chloride, sodium iodide, sodium fluoride, potassium fluoride, sodium nitrate, sodium iodate, sodium hydroxide, fructose, saccharin, glucose, paraffin, beeswax, naphthalene, and gelatin. 7. The method of claim 6 , wherein said porogen after being mixed with said keratin-biomaterial solution is formed into a shape of a cubic, geometrically-shaped crystals, geometric shapes, or mixtures thereof. 8. The method of claim 1 , wherein said biomaterial is selected from group consisting of poly(lactide-co-glycolide) (PLGA), poly(lactide) (PLLA), polyglycolic acid (PGA), polyanhydrides, poly(ortho ethers), poly caprolactone, polyethylene glycol (PEG), polyurethane, copolymers thereof, and mixtures thereof. 9. The method of claim 1 , wherein said keratin is fibrous or powdered. 10. The method of claim 1 , further comprising the step, after mixing keratin with biomaterial solution, adding functional or inert additives to the solution.
Porous materials, {e.g. foams or sponges} · CPC title
Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24 · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title
Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.